Security Snapshot

Immunome Inc. - Common Stock (IMNM) Institutional Ownership

CUSIP: 45257U108

13F Institutional Holders and Ownership History from Q4 2020 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

103

Shares (Excl. Options)

31.45MFull value: 31,448,606 · shares · 30 Sep 2026

Price

$21.51

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
IMNM on Nasdaq
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
31,448,606
Latest holder snapshot 5 signals
Total 13F value
$676,660,953
Portfolio coverage rank
0%
Share change
-1,925,910
Value change
-$41,210,805
Number of holders
103
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
113,602,738
SEC-reported price per share
$19.10
Insider filing price
$19.10
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • IMNM - Immunome Inc. - Common Stock is tracked under CUSIP 45257U108.
  • 103 institutions reported positions in Q3 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 202 to 103 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $2.5BFull value: $2,501,319,018 · USD · 30 Jun 2026
    to
    $676.66MFull value: $676,660,953 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 103 institutions filings for Q3 2026.

Open SEC evidence

Security key

45257U108

13F reference period

Q3 2026

13F holders

103

13D/G owners

9

CIK / CUSIP context first

Open Q3 2026 holders IMNM full holder history Immunome Inc. SEC filings Immunome Inc. company facts Immunome Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
IMNM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 17% +19% $472,441,961 +$79,542,057 19,676,883 +20% T. Rowe Price Investment Management, Inc. 30 Jun 2026
FMR LLC 15% +113% $152,894,064 +$80,670,694 13,056,709 +112% FMR LLC 30 Sep 2025
VANGUARD CAPITAL MANAGEMENT LLC 5% $123,157,183 5,725,578 Vanguard Capital Management 30 Sep 2026
Redmile Group, LLC 4.9% -6% $119,960,738 -$3,442,010 5,558,885 -2.8% Redmile Group, LLC 31 Mar 2026
Sirenia Capital Management LP 4.3% -30% $116,023,019 -$49,525,931 4,832,279 -30% Sirenia Capital Management LP 30 Jun 2026
Immunome Aggregator, LP 6% $40,628,327 4,768,583 Immunome Aggregator, LP 31 Jan 2025
Enavate Sciences GP, LLC 4.3% $73,483,864 4,768,583 Enavate Sciences GP, LLC 18 Dec 2025
EcoR1 Capital, LLC 4.7% $34,756,616 4,079,415 EcoR1 Capital, LLC 31 Mar 2025
JANUS HENDERSON GROUP PLC 2.2% -55% $16,313,738 -$13,130,862 1,914,758 -45% JANUS HENDERSON GROUP PLC 31 Mar 2025
As of 30 Sep 2026, 103 institutional investors reported holding
31.45MFull value: 31,448,606 · shares · 30 Sep 2026
shares of Immunome Inc. - Common Stock (IMNM). This represents 28% of the company’s total
113.6MFull value: 113,602,738 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
26%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 4,882,131 +7.3% 0% $105,014,638
PRIMECAP MANAGEMENT CO/CA/ 4.1% 4,644,821 +1.4% 0.06% $99,910,100
STATE STREET CORP 4% 4,490,152 -18% 0% $96,583,170
GEODE CAPITAL MANAGEMENT, LLC 2.5% 2,815,501 +2.2% 0% $60,573,374
SILVERARC CAPITAL MANAGEMENT, LLC 1.8% 2,092,715 +3.8% 5.5% $45,014,300
MORGAN STANLEY 1.5% 1,688,971 -30% 0% $36,329,803
VANGUARD PORTFOLIO MANAGEMENT LLC 1.1% 1,295,714 -3.9% 0% $27,870,808
VANGUARD FIDUCIARY TRUST CO 0.7% 799,267 +5.7% 0% $17,192,233
Pivotal bioVenture Partners Investment Advisor LLC 0.64% 732,512 0% 6.3% $15,756,333
TD ASSET MANAGEMENT INC 0.62% 701,842 -2.4% 0.01% $15,363,321
NAN FUNG TRINITY (HK) LTD 0.55% 621,079 -13% 1.3% $13,359,409
BNP PARIBAS FINANCIAL MARKETS 0.5% 573,174 0.01% $12,328,973
MARSHALL WACE, LLP 0.46% 518,255 +3.5% 0.01% $11,147,666
Candriam S.C.A. 0.43% 489,853 -28% 0.05% $10,575,236
DIMENSIONAL FUND ADVISORS LP 0.39% 438,241 +19% 0% $9,428,601
FEDERATED HERMES, INC. 0.27% 305,699 +115% 0.01% $6,575,586
ALERUS FINANCIAL NA 0.26% 300,000 -22% 0.28% $6,453,000
Universal- Beteiligungs- und Servicegesellschaft mbH 0.25% 285,627 +23% 0.01% $6,143,836
KENNEDY CAPITAL MANAGEMENT LLC 0.25% 281,064 +1.4% 0.11% $6,045,687
Qube Research & Technologies Ltd 0.25% 279,624 -36% 0.01% $6,014,712
Invesco Ltd. 0.23% 258,085 +274% 0% $5,551,408
TEMA ETFS LLC 0.21% 235,688 -12% 0.19% $5,069,649
Tidal Investments LLC 0.21% 235,688 -12% 0.01% $5,069,649
Swiss National Bank 0.17% 194,600 +7.2% 0% $4,185,846
Verition Fund Management LLC 0.17% 190,099 0.03% $4,089,029

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
24
Headline period
Q3 2026
Rows shown
1-24 of 24
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 31,448,606 $676,660,953 -$41,210,805 $21.51 103
2026 Q2 118,047,208 $2,501,319,018 +$43,265,308 $21.19 202
2026 Q1 116,673,843 $2,544,317,709 -$44,791,172 $21.87 200
2025 Q4 118,329,008 $2,540,756,857 +$630,580,065 $21.48 184
2025 Q3 91,384,562 $1,070,118,014 +$140,281,752 $11.71 153
2025 Q2 79,431,966 $738,692,421 +$30,839,753 $9.30 142
2025 Q1 76,944,016 $518,447,649 +$156,654,047 $6.73 141
2024 Q4 53,313,664 $566,321,086 -$37,080,544 $10.62 119
2024 Q3 51,629,246 $754,701,793 +$58,776,153 $14.62 114
2024 Q2 47,779,242 $578,110,445 +$106,966,991 $12.10 112
2024 Q1 36,616,859 $903,617,775 +$377,900,927 $24.68 102
2023 Q4 21,490,560 $229,948,765 +$205,035,908 $10.70 57
2023 Q3 2,729,076 $22,706,803 +$3,521,335 $8.35 36
2023 Q2 1,949,082 $15,421,801 +$698,301 $7.91 35
2023 Q1 1,860,095 $9,343,739 -$1,198,225 $4.99 30
2022 Q4 2,100,648 $4,845,087 -$694,148 $2.21 28
2022 Q3 2,300,040 $10,208,297 -$14,594 $4.43 23
2022 Q2 2,313,613 $7,426,000 -$1,197,731 $3.21 24
2022 Q1 2,694,238 $15,433,000 -$858,955 $5.68 26
2021 Q4 2,790,928 $36,364,000 +$4,810,967 $12.96 28
2021 Q3 2,391,433 $58,321,000 +$6,054,335 $24.35 31
2021 Q2 2,376,109 $41,107,000 +$6,432,363 $17.30 25
2021 Q1 1,909,240 $64,673,000 +$1,324,022 $33.86 30
2020 Q4 2,013,500 $19,489,000 +$19,489,000 $9.68 24
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .